Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Array Biopharma, Inc. (NQ: ARRY)
5.660 USD  -0.230 (-3.90%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Array Biopharma, Inc.
 
< Previous 1 2 3 4 5 6 7 8 Next >
John A. Orwin Joins Array BioPharma Board Of Directors
November 07, 2012
Industry veteran brings oncology experience, big pharma perspective, and commercial expertise Read More
from PR Newswire
Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
November 06, 2012
from PR Newswire
Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
November 05, 2012
Conference call scheduled today, Monday, November 5, 2012 at 4:30 p.m. ET Read More
from PR Newswire
Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
November 01, 2012
from PR Newswire
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
October 29, 2012
Data on ARRY-520, ARRY-614 and ARRY-797 Expected at Upcoming Scientific Meetings Read More
from PR Newswire
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2013 On October 29, 2012
October 23, 2012
from PR Newswire
Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures
October 11, 2012
Five Star Equities Provides Stock Research on Array Biopharma and Zalicus Read More
from Marketwired News Releases
Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012
September 25, 2012
The Paragon Report Provides Stock Research on Ariad Pharmaceuticals and Array Biopharma Read More
from Marketwired News Releases
Array BioPharma to Present at the UBS Global Life Sciences Conference
September 11, 2012
from Business Wire News Releases
Array BioPharma Announces Changes to Board of Directors
August 31, 2012
from Business Wire News Releases
Array BioPharma to Present at the Stifel Nicolaus Healthcare, NewsMakers in the Biotech Industry and Morgan Stanley Global Healthcare Conferences
August 29, 2012
from Business Wire News Releases
Biotech Industry Soaring in 2012 -- M&A Activity at a Four-Year High as Large Pharmaceuticals Face Major Patent Cliffs
August 17, 2012
Five Star Equities Provides Stock Research on Sarepta Therapeutics and Array Biopharma Read More
from Marketwired News Releases
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
August 13, 2012
from Business Wire News Releases
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 on August 13, 2012
August 06, 2012
from Business Wire News Releases
Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDs
July 31, 2012
from Business Wire News Releases
Array BioPharma Names Andrew Robbins as Senior Vice President, Commercial Operations
July 24, 2012
from Business Wire News Releases
Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration
July 19, 2012
from Business Wire News Releases
Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel Mutant KIT Inhibitor
July 16, 2012
from Business Wire News Releases
Array BioPharma to Present at the JMP Securities Healthcare Conference 2012
July 03, 2012
from Business Wire News Releases
Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCO
June 04, 2012
from Business Wire News Releases
MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial
June 04, 2012
from Business Wire News Releases
Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference
May 30, 2012
from Business Wire News Releases
Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting
May 16, 2012
from Business Wire News Releases
Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012
May 14, 2012
from Business Wire News Releases
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012
April 30, 2012
from Business Wire News Releases
Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors
April 30, 2012
from Business Wire News Releases
Array BioPharma Names Ron Squarer Chief Executive Officer
April 26, 2012
from Business Wire News Releases
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012
April 23, 2012
from Business Wire News Releases
Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance
April 16, 2012
from Business Wire News Releases
Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer
April 04, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here